
1.67BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US14070B3096
CUSIP
14070B309
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
0.38
Book Value
4.83
Dividend Share
-
Dividend Yield
-
Earnings Share
-2.32
Wall Street Target Price
54.11
EPS Estimate Current Year
-0.39
EPS Estimate Next Year
-0.76
EPS Estimate Current Quarter
-0.5417
EPS Estimate Next Quarter
-0.5875
Most Recent Quarter
-
Revenue TTM
11,130,509
Gross Profit TTM
-92,915,936
EBITDA
-117,913,776
Profit Margin
0.00%
Return On Assets TTM
-31.23%
Return On Equity TTM
-56.40%
Revenue Per Share TTM
0.245
Qtly Revenue Growth YOY
-7.90%
Diluted Eps TTM
-2.32
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
78
Price Sales TTM
124.4331
Price Book MRQ
5.9854
Enterprise Value Revenue
141
Enterprise Value EBITDA
-2
283.89
3.04%136.01
1.42%17.40
0.75%294.30
0.33%803.19
0.00%630.30
-11.57%434.31
-3.61%797.77
-2.91%147.30
-1.49%68.51
-0.71%